1. Treatment Outcome of Nab-paclitaxel Plus Gemcitabine for Leptomeningeal Carcinomatosis from Pancreatic Ductal Adenocarcinoma: An Autopsy Case Report
- Author
-
Masahiro Ogawa, Daiichiro Kikuta, Takuji Gotoda, Hitoshi Shibuya, Kenji Yamao, Hiroshi Nakagawara, Kunio Iwatsuka, Akihiro Hemmi, and Mitsuhiko Moriyama
- Subjects
medicine.medical_specialty ,Paclitaxel ,medicine.medical_treatment ,leptomeningeal carcinomatosis ,pancreatic ductal adenocarcinoma ,Case Report ,Autopsy ,Adenocarcinoma ,030204 cardiovascular system & hematology ,chemotherapy ,Deoxycytidine ,radiation therapy ,03 medical and health sciences ,0302 clinical medicine ,Albumins ,Antineoplastic Combined Chemotherapy Protocols ,Internal Medicine ,medicine ,Pancreatic mass ,Humans ,Pathological ,Chemotherapy ,medicine.diagnostic_test ,business.industry ,General Medicine ,Middle Aged ,medicine.disease ,Gemcitabine ,Pancreatic Neoplasms ,Radiation therapy ,Treatment Outcome ,Fine-needle aspiration ,Female ,030211 gastroenterology & hepatology ,Radiology ,business ,Meningeal Carcinomatosis ,medicine.drug - Abstract
A 57-year-old woman with a sudden-onset seizure was hospitalized. Brain magnetic resonance imaging findings led to a suspicion of leptomeningeal carcinomatosis (LMC) without a brain parenchymal tumor, and abdominal computed tomography showed a tumor in the pancreatic tail. Endoscopic ultrasonography-guided fine needle aspiration of the pancreatic mass revealed adenocarcinoma. Therefore, LMC from pancreatic ductal adenocarcinoma was strongly suspected. She received three courses of nab-paclitaxel plus gemcitabine and whole-brain radiation. Shortly thereafter, she developed a severe consciousness impediment and died. A pathological autopsy showed adenocarcinoma in a wide area of the leptomeninges.
- Published
- 2021